These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action. Dawidowicz AL; Olszowy-Tomczyk M; Typek R Fitoterapia; 2021 Jul; 152():104915. PubMed ID: 33964342 [TBL] [Abstract][Full Text] [Related]
25. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification. Peschel W; Politi M Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837 [TBL] [Abstract][Full Text] [Related]
26. The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling. Lah TT; Majc B; Novak M; Sušnik A; Breznik B; Porčnik A; Bošnjak R; Sadikov A; Malavolta M; Halilčević S; Mlakar J; Zomer R Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497400 [TBL] [Abstract][Full Text] [Related]
27. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780 [TBL] [Abstract][Full Text] [Related]
28. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se. Hill AJ; Jones NA; Smith I; Hill CL; Williams CM; Stephens GJ; Whalley BJ Neurosci Lett; 2014 Apr; 566():269-74. PubMed ID: 24642454 [TBL] [Abstract][Full Text] [Related]
29. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. De Petrocellis L; Vellani V; Schiano-Moriello A; Marini P; Magherini PC; Orlando P; Di Marzo V J Pharmacol Exp Ther; 2008 Jun; 325(3):1007-15. PubMed ID: 18354058 [TBL] [Abstract][Full Text] [Related]
30. An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma. Colvin EK; Hudson AL; Anderson LL; Kumar RP; McGregor IS; Howell VM; Arnold JC Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954477 [TBL] [Abstract][Full Text] [Related]
31. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms. De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963 [TBL] [Abstract][Full Text] [Related]
32. Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice. Khajuria DK; Karuppagounder V; Nowak I; Sepulveda DE; Lewis GS; Norbury CC; Raup-Konsavage WM; Vrana KE; Kamal F; Elbarbary RA J Bone Miner Res; 2023 Nov; 38(11):1560-1576. PubMed ID: 37597163 [TBL] [Abstract][Full Text] [Related]
33. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Guzmán M; Duarte MJ; Blázquez C; Ravina J; Rosa MC; Galve-Roperh I; Sánchez C; Velasco G; González-Feria L Br J Cancer; 2006 Jul; 95(2):197-203. PubMed ID: 16804518 [TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro. Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991 [TBL] [Abstract][Full Text] [Related]
35. Raman-Based Differentiation of Hemp, Cannabidiol-Rich Hemp, and Cannabis. Sanchez L; Baltensperger D; Kurouski D Anal Chem; 2020 Jun; 92(11):7733-7737. PubMed ID: 32401504 [TBL] [Abstract][Full Text] [Related]
36. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Borrelli F; Pagano E; Romano B; Panzera S; Maiello F; Coppola D; De Petrocellis L; Buono L; Orlando P; Izzo AA Carcinogenesis; 2014 Dec; 35(12):2787-97. PubMed ID: 25269802 [TBL] [Abstract][Full Text] [Related]
37. Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation. Vacek J; Vostalova J; Papouskova B; Skarupova D; Kos M; Kabelac M; Storch J Free Radic Biol Med; 2021 Feb; 164():258-270. PubMed ID: 33453360 [TBL] [Abstract][Full Text] [Related]
38. Cannabigerol and cannabichromene in Zagožen M; Čerenak A; Kreft S Acta Pharm; 2021 Sep; 71(3):355-364. PubMed ID: 36654096 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83. Cerretani D; Collodel G; Brizzi A; Fiaschi AI; Menchiari A; Moretti E; Moltoni L; Micheli L Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752303 [TBL] [Abstract][Full Text] [Related]
40. Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. Brierley DI; Harman JR; Giallourou N; Leishman E; Roashan AE; Mellows BAD; Bradshaw HB; Swann JR; Patel K; Whalley BJ; Williams CM J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):844-859. PubMed ID: 31035309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]